By comprehensively analysing the expression profile of RFX1 in pan-cancer, we found that RFX1 has higher expression in digestive tract tumors, including colon, cholangiocarcinoma and gastric cancer, compared to normal paraneoplastic tissues (Fig. 1A). Here, RFX1 is linked to gastric cancer.